Tech Company Financing Transactions
Myrobalan Therapeutics Funding Round
Myrobalan Therapeutics secured a $24 million Series A investment round on 1/10/2024. Investors included Co-win Healthcare Fund and 3E Bioventures.
Transaction Overview
Company Name
Announced On
1/10/2024
Transaction Type
Venture Equity
Amount
$24,000,000
Round
Series A
Investors
Co-win Healthcare Fund (Lead Investor)
Proceeds Purpose
The company intends to use the funds to advance its first program into the clinic.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
200 Boston Avenue
Medford, MA 02155
USA
Medford, MA 02155
USA
Phone
Undisclosed
Website
Email Address
Overview
Our comprehensive research and development expertise, covering all stages of drug development, is intended to foster coherent decision making. We have confidence in the successful entrepreneurial experience of our founders in building and growing startup biotech companies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jing Wang
Founder
Guoping Feng
Founder
Zhigang He
Vice President
Bolin Geng
VP - Bus. Development
Debarun Gupta
VP - Operations
Jessica Herbst
Browse more venture capital transactions:
Prev: 1/10/2024: Sunrise AI venture capital transaction
Next: 1/10/2024: Karma Wallet venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs